Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NM 004

X
Drug Profile

NM 004

Alternative Names: 5-ASA+4-APAA; Apaza™; INN-108; NAA-004; NM-004

Latest Information Update: 23 Mar 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biocon
  • Developer 9 Meters Biopharma
  • Class Anti-inflammatories; Nitrogen compounds; Phenylacetates; Radioprotectives; Salicylic acids; Small molecules
  • Mechanism of Action Immunomodulators; Interleukin 2 stimulants; Lipoxygenase-cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Ulcerative colitis
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Inflammatory bowel diseases; Radiation injuries; Ulcerative colitis

Most Recent Events

  • 23 Mar 2023 Discontinued - Phase-I for Ulcerative colitis (In adolescents, In children, In the elderly, In infants, In neonates, In adults) in USA (PO)
  • 22 Mar 2023 Discontinued - Phase-I for Ulcerative colitis (In adults) in USA (PO)
  • 19 Jul 2022 Discontinued - Phase-I for Inflammatory bowel diseases in USA (PO) (9 Meters Biopharma pipeline, July 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top